Drug Type Monoclonal antibody |
Synonyms antiPROSCA, antiPROSCA monoclonal antibodies |
Target- |
Action modulators |
Mechanism Immunomodulators |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingClinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Ovarian Epithelial Carcinoma | Clinical | Belgium | - | |
| Ovarian Epithelial Carcinoma | Clinical | Thailand | - | |
| Colorectal Cancer | Preclinical | Belgium | - | |
| Melanoma | Preclinical | United Kingdom | - | |
| Prostatic Cancer | Preclinical | Belgium | - |






